Development and validation of the Kilifi stigma scale for epilepsy in Kenya (Publications)
The aim of this study was to develop and validate a tool to measure perceived stigma among people with epilepsy (PWE) in Kilifi, Kenya. We reviewed existing scales that measured stigma, particularly o
Relationship of atmospheric pollution characterized by gas NO2 and particles (PM10) to microbial communities living in bryophytes at three differently... (Publications)
Atmospheric pollution has become a major problem for modern societies owing to its fatal effects on both human health and ecosystems. We studied the relationships of nitrogen dioxide atmospheric pollu
Culture, changing livelihoods, and HIV/AIDS discourse: reframing the institutionalization of fish-for-sex exchange in the Zambian Kafue Flats (Publications)
Discussions about the cultural dimensions of the spread of HIV/AIDS in Africa persist. Drawing ondata on fish-for-sex deals between local Ila or Tonga women and immigrant fishermen in theZambian Kafue
Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study (Publications)
BACKGROUND: Many people with epilepsy in low-income countries do not receive appropriate biomedical treatment. This epilepsy treatment gap might be caused by patients not seeking biomedical treatment
Behavior of sunbed users in Switzerland (Publications)
OBJECTIVES: A constant rise in the number of skin cancer cases has been observed during the last few years. An important reason for this trend is that exposure of the population to UV radiation is hig
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials (Publications)
AIMS: To asses the safety and pharmacokinetics of a new synthetic ozonide antimalarial, OZ439, in a first-in-man, double-blind study in healthy volunteers. METHODS: OZ439 was administered as single or
Melarsoprol refractory <em>T. b. gambiense</em> from Omugo, north-western Uganda (Publications)
Culture adapted T. b. gambiense isolated from Northwest Uganda were exposed to 0.001-0.14 microg/ml melarsoprol or 1.56-100 microg/ml DL-alpha-difluoromethylornithine (DFMO). Minimum inhibitory concen